AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. OGEN
  4. [EFFECT] Oragenics Inc. SEC Filing

[EFFECT] Oragenics Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 4:30 P.M.
Form: S-1
CIK: 0001174940
Company Name: ORAGENICS INC
File Number: 333-288225

Source:

Stock OGEN logo
Oragenics

NYSE:OGEN

OGEN Rankings

#10727 Ranked by Market Cap
N/A Ranked by Dividends
#144 Top Gainer

OGEN Latest News

Jul 1, 2025
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants
Jun 10, 2025
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
May 28, 2025
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
May 13, 2025
Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia
May 12, 2025
Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision

OGEN Latest SEC Filings

Jun 30, 2025
[S-1/A] Oragenics Inc. Amends IPO Registration Statement
Jun 23, 2025
[S-1] Oragenics Inc. Files IPO Registration Statement
Jun 18, 2025
[Form 4] Oragenics Inc. Insider Trading Activity

OGEN Stock Data

2.55M
698.42k
13.3%
1.14%
2.86%
Biotechnology
Pharmaceutical Preparations
United States
SARASOTA